Indeed, VEGFR-TKI’s have been associated with reversal of immune suppression in the tumor microenvironment through reduction of regulatory T-cells and myeloid-derived suppressor cells and this may enhance the efficacy of immunotherapeutic agents [26-28]. Here, KDR is linked to neoplasm.